This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada
, you can request alternate formats on the "Contact Us" page.
Volume 33-13, December 1, 2007
Volume 33-12, November 1, 2007
Volume 33-04, February 15, 2007
Volume 33-03, February 1, 2007
Volume 33-02, January 15, 2007
Advisory Committee Statements and Supplements to the CCDR
An Advisory Committee Statement
(ACS)
National Advisory Committee on Immunization (NACI)
Meningococcal C conjugate vaccination recommendations for infants
ACS- 11 - November 2007
An Advisory Committee Statement
(ACS)
Canadian Tuberculosis Committee
Interferon gamma release assays for latent tuberculosis infection
ACS- 10 - 1 November 2007
An Advisory Committee Statement
(ACS)
Canadian Tuberculosis Committee
Housing conditions that serve as risk factors
for tuberculosis infection and disease
ACS- 9 - 1 October 2007
An Advisory Committee Statement
(ACS)
National Advisory Committee on Immunization (NACI)
Statement on Mumps Vaccine
ACS- 8 - 1 August 2007
An Advisory Committee Statement
(ACS)
National Advisory Committee on Immunization (NACI)
Statement on Influenza Vaccination
for the 2007-2008 Season
ACS- 7 - 1 July 2007
An Advisory Committee Statement
(ACS)
National Advisory Committee on Immunization (NACI)
Thimerosal: Updated Statement
ACS- 6 - 1 July 2007
An Advisory Committee Statement
(ACS)
Committee to Advise on Tropical Medicine and
Travel (CATMAT)
Statement
on high-altitude illnesses
ACS- 5 - 1 April 2007
An Advisory Committee Statement
(ACS)
Committee to Advise on Tropical Medicine and
Travel (CATMAT)
The
Immunocompromised Traveller
ACS- 4 - 1 April 2007
An Advisory Committee Statement
(ACS)
National Advisory Committee on
Immunization (NACI)
Statement
on conjugate meningococcal vaccine for
serogroups A, C, Y and W135
ACS -3 - 1 May 2007
An Advisory Committee Statement
(ACS)
National Advisory Committee on
Immunization (NACI)
Statement
on human papillomavirus
vaccine
ACS -2 - 15 February 2007
An Advisory Committee Statement
(ACS)
National Advisory Committee on
Immunization (NACI)
Statement
on the recommended use of pentavalent and
hexavalent vaccines
ACS -1 - 1 February 2007
Point-of-Care HIV Testing Using Rapid HIV Test Kits: Guidance for Health-Care Professionals
CCDR Volume 33S2, November 2007
2004 Canadian Sexually
Transmitted Infections Surveillance Report
CCDR Volume 33S1, May 2007
To share this page just click on the social network icon of your choice.